IMARA INC.

IMRA
Real-time Estimate Quote. Real-time Estimate  - 07/13 01:52:57 pm
24.585USD -1.46%
Prev.24.9500
Open24.6500
High25.8257
Low24.0200
Volume18 462
Latest news
06/29
06/25
06/24
06/12
Chart IMARA INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance38,054,947,1
Spread/Res.-35%-55%-48%
Spread/Supp.7,3%59%57%
Support23,015,515,8
Financials
Sales 2020 - - -
Net income 2020 -46,3 M - -
Net cash 2020 57,2 M - -
P/E ratio 2020 -7,65x
Yield 2020 -
Capitalization 431 M 431 M -
EV / Sales 2019
EV / Sales 2020 -
Nbr of Employees 16
Free-Float 76,8%
Company
Imara, Inc. is a clinical-stage biopharmaceutical company. The Company is developing and commercializing therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. The Company’s product pipeline include IMR-687, which is an oral, once-a-day, potentially...
Sector :
Biotechnology & Medical Research - NEC
Calendar :
No events available

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 44,33 $
Last Close Price 24,95 $
Spread / Highest target 157%
Spread / Average Target 77,7%
Spread / Lowest Target 36,3%